TickerFactsScreenerDevelopers

BIOCRYST PHARMACEUTICALS INC (BCRX) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2009: -$16.22M2010: -$28.55M2011: -$32.25M2012: -$37.40M2013: -$26.53M2015: -$13.12M2016: -$53.44M2017: -$41.14M2018: -$92.56M2019: -$89.58M2020: -$135.11M2021: -$142.16M2022: -$161.85M2023: -$95.14M2024: -$52.02M2025: $347.37M$347.37M
2009Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025$347.37M+767.8%
2024-$52.02M+45.3%
2023-$95.14M+41.2%
2022-$161.85M-13.9%
2021-$142.16M-5.2%
2020-$135.11M-50.8%
2019-$89.58M+3.2%
2018-$92.56M-125.0%
2017-$41.14M+23.0%
2016-$53.44M-307.4%
2015-$13.12M—
2013-$26.53M+29.1%
2012-$37.40M-16.0%
2011-$32.25M-12.9%
2010-$28.55M-76.1%
2009-$16.22M—